David Michael Johnson - 10 Jun 2022 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder, Attorney-in-fact
Issuer symbol
AURA
Transactions as of
10 Jun 2022
Net transactions value
+$716,300
Form type
4
Filing time
14 Jun 2022, 21:29:20 UTC
Previous filing
10 Jun 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Purchase $45,120 +3,000 $15.04 3,000 10 Jun 2022 By NEJ09 IRREVOCABLE TRUST F1
transaction AURA Common Stock Purchase $45,120 +3,000 $15.04 3,000 10 Jun 2022 By NEJ12 IRREVOCABLE TRUST F2
transaction AURA Common Stock Purchase $150,400 +10,000 $15.04 10,000 10 Jun 2022 Direct
transaction AURA Common Stock Purchase $97,930 +7,000 +233% $13.99 10,000 13 Jun 2022 By NEJ09 IRREVOCABLE TRUST F1
transaction AURA Common Stock Purchase $97,930 +7,000 +233% $13.99 10,000 13 Jun 2022 By NEJ12 IRREVOCABLE TRUST F2
transaction AURA Common Stock Purchase $279,800 +20,000 +200% $13.99 30,000 13 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F2 The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.